Anthropic

Novo Nordisk head office
#Anthropic #Artificial intelligence (AI) #Cardiometabolic diseases #Collaboration #Novo Nordisk

New deals boost Novo Nordisk’s AI drug discovery ambitions

Novo Nordisk and Orbis Medicines have announced a strategic collaboration and license agreement to discover and develop oral macrocycle therapeutics for cardiometabolic diseases.   Under the terms of the agreement, Orbis Medicines is eligible to receive up to $1.4 billion in upfront and potential development and commercial milestone payments, in addition… Read More

#Business & Investment #News

Claude AI app
#AI / data analytics / healthtech / informatics #Anthropic #Artificial intelligence (AI) #Drug discovery

Anthropic launches into drug discovery with Claude Science

Anthropic has launched Claude Science, an app that it says integrates the tools and packages that researchers most commonly use, produces auditable artifacts, and provides flexible access to computing resources.  At the launch event, the company also announced that it will be using the product to pursue some of its… Read More

#Business & Investment #Editor's Choice #News #Trending News